New combo pill aims to curb weight gain in teens on antipsychotics
NCT ID NCT05303064
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study tests whether a combination drug called OLZ/SAM (olanzapine plus samidorphan) causes less weight gain than olanzapine alone in teenagers with schizophrenia or bipolar I disorder. About 220 teens aged 10-17 will take either the combo or olanzapine for 52 weeks. The main goal is to see if the combo leads to a smaller increase in body mass index (BMI).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- OLZ/SAM (olanzapine and samidorphan combination)
- What this could lead to
- If successful, this could offer a way to control psychiatric symptoms with less weight gain, improving long-term health for teens.
- What could go wrong
- This is an early Phase 3 trial with only 220 participants, so results may not apply to everyone. Weight gain may still occur, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR I DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alkermes Investigational Site
WITHDRAWNKinston, North Carolina, 28504, United States
-
Alkermes Investigational Site
RECRUITINGRichmond, Virginia, 23220, United States
-
Alkermes Investigator Site
RECRUITINGDothan, Alabama, 36303, United States
-
Alkermes Investigator Site
RECRUITINGLittle Rock, Arkansas, 72204, United States
-
Alkermes Investigator Site
WITHDRAWNEncino, California, 91316, United States
-
Alkermes Investigator Site
RECRUITINGStanford, California, 94305, United States
-
Alkermes Investigator Site
WITHDRAWNUpland, California, 91786, United States
-
Alkermes Investigator Site
WITHDRAWNColorado Springs, Colorado, 80910, United States
-
Alkermes Investigator Site
ACTIVE_NOT_RECRUITINGDenver, Colorado, 80202, United States
-
Alkermes Investigator Site
WITHDRAWNHartford, Connecticut, 06106, United States
-
Alkermes Investigator Site
RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Alkermes Investigator Site
WITHDRAWNMiami, Florida, 33155, United States
-
Alkermes Investigator Site
RECRUITINGMiami Lakes, Florida, 33016, United States
-
Alkermes Investigator Site
RECRUITINGDecatur, Georgia, 30030, United States
-
Alkermes Investigator Site
RECRUITINGChicago, Illinois, 60611, United States
-
Alkermes Investigator Site
RECRUITINGIndianapolis, Indiana, 46202, United States
-
Alkermes Investigator Site
RECRUITINGSaint Charles, Missouri, 63304, United States
-
Alkermes Investigator Site
RECRUITINGLincoln, Nebraska, 68526, United States
-
Alkermes Investigator Site
WITHDRAWNOmaha, Nebraska, 68198, United States
-
Alkermes Investigator Site
WITHDRAWNParamus, New Jersey, 07652, United States
-
Alkermes Investigator Site
RECRUITINGNew York, New York, 10016, United States
-
Alkermes Investigator Site
RECRUITINGCincinnati, Ohio, 45219, United States
-
Alkermes Investigator Site
RECRUITINGWest Chester, Ohio, 45069, United States
-
Alkermes Investigator Site
TERMINATEDDeSoto, Texas, 75115, United States
-
Alkermes Investigator Site
WITHDRAWNFort Worth, Texas, 76104, United States
-
Alkermes Investigator Site
RECRUITINGEverett, Washington, 98201, United States
-
Alkermes Investigator Site
RECRUITINGLa Plata, Buenos Aires, 1900, Argentina
-
Alkermes Investigator Site
RECRUITINGLa Plata, Buenos Aires, C1199ABB, Argentina
-
Alkermes Investigator Site
RECRUITINGBuenos Aires, C1133AAH, Argentina
-
Alkermes Investigator Site
RECRUITINGCórdoba, X5003DCE, Argentina
-
Alkermes Investigator Site
RECRUITINGMendoza, 5500, Argentina
-
Alkermes Investigator Site
RECRUITINGFortaleza, Ceará, 60430-140, Brazil
-
Alkermes Investigator Site
RECRUITINGCuritiba, Paraná, 80240-280, Brazil
-
Alkermes Investigator Site
RECRUITINGGoiânia, 74093-040, Brazil
-
Alkermes Investigator Site
RECRUITINGRio de Janeiro, 22270-060, Brazil
-
Alkermes Investigator Site
RECRUITINGSão Paulo, 01228-000, Brazil
-
Alkermes Investigator Site
RECRUITINGSão Paulo, 05403-010, Brazil
-
Alkermes Investigator Site
RECRUITINGBarranquilla, 110121, Colombia
-
Alkermes Investigator Site
RECRUITINGBello, 51053, Colombia
-
Alkermes Investigator Site
ACTIVE_NOT_RECRUITINGBogotá, 111166, Colombia
-
Alkermes Investigator Site
RECRUITINGBogotá, 80020, Colombia
-
Alkermes Investigator Site
RECRUITINGPereira, 660003, Colombia
-
Alkermes Investigator Site
RECRUITINGCuliacán, 80230, Mexico
-
Alkermes Investigator Site
RECRUITINGEstado de México, C.P. 07000, Mexico
-
Alkermes Investigator Site
RECRUITINGLeón, 37000, Mexico
-
Alkermes Investigator Site
RECRUITINGMonterrey, 64620, Mexico
-
Alkermes Investigator Site
RECRUITINGMonterrey, 64710, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?